Key facts
- Omega Fund VI, L.P. filed SCHEDULE 13G/A for Lexeo Therapeutics, Inc. Common Stock, $0.0001 par value per share (LXEO).
- Disclosed ownership: 3.6%.
- Date of event: 31 Dec 2024.
Key filing fact
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting persons
Names, ownership, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Omega Fund VI, L.P. | 3.6% | 1,184,636 | 0 | 1,184,636 | /s/ Otello Stampacchia | Otello Stampacchia, Director of General Partner of General Partner | |
| Omega Fund VI GP, L.P. | 3.6% | 1,184,636 | 0 | 1,184,636 | /s/ Otello Stampacchia | Otello Stampacchia, Director of General Partner | |
| Omega Fund VI GP Manager, Ltd. | 3.6% | 1,184,636 | 0 | 1,184,636 | /s/ Otello Stampacchia | Otello Stampacchia, Director | |
| Claudio Nessi | 3.6% | 1,184,636 | 0 | 1,184,636 | /s/ Otello Stampacchia | Otello Stampacchia, Attorney-in-Fact | |
| Otello Stampacchia | 3.6% | 1,184,636 | 0 | 1,184,636 | /s/ Otello Stampacchia | Otello Stampacchia | |
| Francesco Draetta | 3.6% | 1,184,636 | 0 | 1,184,636 | /s/ Otello Stampacchia | Otello Stampacchia, Attorney-in-Fact |
CIK / CUSIP context first